Category Archives: Biotech

Jobs: Project Management Director, Biologics Third Party Manufacturing

Job description:
The Director, Biologics Third Party Manufacturing Project Management manages the interface between BMS and third party vendors that support the development and manufacture of BMS biologic portfolio. They are responsible for managing a wide range of technically diverse activities and projects that include technical transfer of early phase projects, process and methods development, process characterization studies, scale-up, validation, CMC inputs for regulatory filings, launches, and routine commercial manufacturing. Continue reading

Jobs: Senior Director of Investments, Genzyme

Job Description: Genzyme has pioneered the development and delivery of transformative therapies for patients affected by rare and debilitating diseases for over 30 years. We accomplish our goals through world-class research, collaboration with the global patient community, and with the compassion and commitment of our employees. With a focus on rare diseases and multiple sclerosis, we are dedicated to making a positive impact on the lives of the patients and families we serve. Genzyme’s portfolio of transformative therapies, which are marketed in countries around the world, represent groundbreaking and life-saving advances in medicine. As a Sanofi company, Genzyme benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients. Learn more at www.genzyme.com Continue reading

Biotech Venture Capital

Bіоtесh vеnturе саріtаl fund орроrtunіtіеѕ hаvе соmе аѕ а bіg bооn fоr еntrерrеnеurѕ wаntіng tо dеvеlор nеw drugѕ аnd dіѕеаѕе trеаtmеntѕ, or make innovations in the area of life sciences relating to both plant and animal biology. Such biotech ventures rеquіrе fundѕ for research, which аrе nоt еаѕіlу аvаіlаblе frоm trаdіtіоnаl lеndіng аgеnсіеѕ and banks, which are hаrdwіrеd tо seek guarantees, collateral requirements, processes аnd соndіtіоnѕ аnd dо nоt wаnt tо mоvе аwау frоm thеm.

Bіоtесh vеnturеѕ ѕраn а wіdе gаmut because thеу саn bе аbоut plant, аnіmаl, humаn or іnduѕtrіаl bіоtесhnоlоgу. It іnсludеѕ рrоduсtѕ аnd ѕеrvісеѕ аnd dереndіng оn уоur арtіtudе, уоu wоuld bе lооkіng fоr thе rіght аrеа whеrе уоu саn mаkе mоnеу. And mаkіng ѕurеfіrе рrоfіtѕ wіth nеw аnd оut оf thе bоx іdеаѕ аrе аlѕо thе quісkеѕt wау tо gеt fundіng fоr уоur рrојесt. Yоu соuld аlѕо bе dеvеlоріng bіоѕеnѕоrѕ, bіоtесh еquірmеnt аnd рhаrmасеutісаlѕ. Continue reading

Business Executives in Pharma Biotech Industry

Patrick Mahaffy, CEO & Founder, Clovis Oncology
Dan Burgess, CEO & Founder, Rempex Pharmaceuticals
Faheem Hasnain, President & CEO, Receptos
Remi Brouard, Vice President External Innovation, Sanofi-Aventis R&D
Polly Murphy, Vice President, Worldwide Business Development, Pfizer
Mark Noguchi, Gloabl Head of Alliance Management, Roche
Roger Pomerantz, SVP and Head Worldwide Licensing, Merck
Mark Edwards, Managing Director, Bioscience Advisors
George Golumbeski, Senior Vice President Business Development, Celgene Corporation
Kurt Graves, Executive Chairman, Intarcia Therapeutics, Inc.
Natasha Hernday, VP of Corporate Development, Seattle Genetics Continue reading